Moderna to Report Third Quarter 2026 Financial Results
News related to:Moderna, Inc · 1 min read
CAMBRIDGE, Mass., October 13, 2026 /CourierPR/ -- Moderna, Inc., a leader in mRNA medicine, is set to report its financial results for the third quarter of 2026. The company will host a live conference call and webcast on Friday, November 6, 2026, at 8:00 a.m. Eastern Time. Investors and the public can access the webcast through the company’s website, which will also provide an archived version available for one year following the event.
Moderna, founded on the premise of advancing mRNA technology, has been at the forefront of developing vaccines and therapeutics for a wide range of diseases. The upcoming financial results will provide insights into the company’s performance during a critical period, reflecting its ongoing efforts in research and development.
The live webcast will be accessible under the "Events and Presentations" section of the Investors page on Moderna’s website. Participants are encouraged to log in early to ensure a smooth experience. The archived version will be available approximately two hours after the call, offering a convenient option for those unable to attend the live session.
As a pioneer in mRNA medicine, Moderna continues to drive innovation in the field, aiming to deliver significant impacts through its mRNA medicines. The financial results will be a key indicator of the company’s progress and future prospects in this rapidly evolving sector.